These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 1317637

  • 1. Contraception after thirty-five.
    Luukkainen T.
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):169-74. PubMed ID: 1317637
    [Abstract] [Full Text] [Related]

  • 2. Hormonal intrauterine devices.
    Rybo G, Andersson K, Odlind V.
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [Abstract] [Full Text] [Related]

  • 3. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I, Stern J, Diaz J, Diaz MM, Faundes A, el Mahgoub S, Diaz S, Pavez M, Coutinho E, Mattos CE.
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [Abstract] [Full Text] [Related]

  • 4. Canadian Contraception Consensus (Part 2 of 4).
    Black A, Guilbert E, Co-Authors, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Special Contributors, Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N.
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [Abstract] [Full Text] [Related]

  • 5. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

  • 6. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Mansouri S.
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [Abstract] [Full Text] [Related]

  • 7. Canadian Contraception Consensus (Part 1 of 4).
    Black A, Guilbert E, Co-Authors, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Special Contributors, Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N, Society of Obstetricians and Gynaecologists of Canada.
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [Abstract] [Full Text] [Related]

  • 8. Acceptability of IUDs is increasing.
    Finger WR, Barr D.
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC.
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [Abstract] [Full Text] [Related]

  • 10. Contraception for the older woman.
    Guillebaud J.
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S70-7. PubMed ID: 12268772
    [Abstract] [Full Text] [Related]

  • 11. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [Abstract] [Full Text] [Related]

  • 12. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I, el Mahgoub S, McCarthy T, Mishell DR, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A.
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [Abstract] [Full Text] [Related]

  • 13. [The acceptability of current contraceptive methods to adolescents].
    Sotnikova EI, Dubnitskaia LV, Perminova SG.
    Akush Ginekol (Mosk); 1993 Oct; (3):26-30. PubMed ID: 8048682
    [Abstract] [Full Text] [Related]

  • 14. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA, Feldblum PJ, Raymond EG.
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [Abstract] [Full Text] [Related]

  • 15. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T, Allonen H, Haukkamaa M, Lähteenmäki P, Nilsson CG, Toivonen J.
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [Abstract] [Full Text] [Related]

  • 16. Reversible contraception for the woman over 35 years of age.
    Archer DF.
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [Abstract] [Full Text] [Related]

  • 17. Choice of contraceptive modality by women in Norway.
    Skjeldestad FE.
    Acta Obstet Gynecol Scand; 1994 Jan; 73(1):48-52. PubMed ID: 8304025
    [Abstract] [Full Text] [Related]

  • 18. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD.
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [Abstract] [Full Text] [Related]

  • 19. Fertility after contraception or abortion.
    Huggins GR, Cullins VE.
    Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
    [Abstract] [Full Text] [Related]

  • 20. Adolescent contraception.
    Kreutner AK.
    Pediatr Clin North Am; 1981 May; 28(2):455-73. PubMed ID: 7243372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.